Natus Medical (NASDAQ:BABY) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a report issued on Saturday.
Separately, Zacks Investment Research upgraded shares of Natus Medical from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a report on Tuesday, October 24th. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $46.50.
Natus Medical (BABY) opened at $37.60 on Friday. The company has a current ratio of 4.21, a quick ratio of 3.36 and a debt-to-equity ratio of 0.36. The firm has a market cap of $1,191.65, a P/E ratio of 24.68 and a beta of 0.84. Natus Medical has a 1 year low of $31.65 and a 1 year high of $43.60.
Natus Medical (NASDAQ:BABY) last released its earnings results on Wednesday, October 25th. The medical equipment provider reported $0.40 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.02. The company had revenue of $122.60 million for the quarter, compared to analyst estimates of $122.41 million. Natus Medical had a negative net margin of 0.62% and a positive return on equity of 12.06%. The firm’s quarterly revenue was up 34.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.39 EPS. analysts expect that Natus Medical will post 1.74 earnings per share for the current fiscal year.
In other Natus Medical news, VP Dong Chune Christopher Chung sold 12,642 shares of the stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $42.91, for a total transaction of $542,468.22. Following the sale, the vice president now directly owns 141,414 shares in the company, valued at approximately $6,068,074.74. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director William M. Moore sold 5,000 shares of the stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $41.01, for a total transaction of $205,050.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,042 shares of company stock worth $902,266. 5.50% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in BABY. Koch Industries Inc. raised its holdings in shares of Natus Medical by 7,423.5% in the 2nd quarter. Koch Industries Inc. now owns 462,472 shares of the medical equipment provider’s stock valued at $450,000 after purchasing an additional 456,325 shares in the last quarter. Hillcrest Asset Management LLC acquired a new stake in shares of Natus Medical in the 3rd quarter valued at $8,966,000. Daruma Capital Management LLC raised its holdings in shares of Natus Medical by 13.1% in the 2nd quarter. Daruma Capital Management LLC now owns 1,470,839 shares of the medical equipment provider’s stock valued at $54,862,000 after purchasing an additional 169,890 shares in the last quarter. Marshall Wace North America L.P. acquired a new stake in shares of Natus Medical in the 2nd quarter valued at $5,832,000. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Natus Medical by 10.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,552,938 shares of the medical equipment provider’s stock valued at $57,924,000 after purchasing an additional 151,372 shares in the last quarter. Institutional investors own 94.39% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Natus Medical (BABY) Downgraded by BidaskClub” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/09/natus-medical-baby-downgraded-by-bidaskclub.html.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.